Lexicon Pharmaceuticals, Inc. (LXRX)
2.23
-0.10
(-4.29%)
USD |
NASDAQ |
May 15, 16:00
2.13
-0.10
(-4.48%)
Pre-Market: 08:57
Lexicon Pharmaceuticals Shareholders Equity (Quarterly) : 202.86M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 562.30M |
| Liquidia Corp. | 108.58M |
| Novo Nordisk A/S | 31.31B |
| Emmaus Life Sciences, Inc. | -67.86M |
| Nutriband, Inc. | 6.680M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 268.82M |
| Total Liabilities (Quarterly) | 65.96M |
| Debt to Equity Ratio | 0.2845 |
| Current Ratio | 18.79 |
| Net Debt Paydown Yield | 1.46% |